SCHEMBL22170387

SCHEMBL22170387

N#Cc1cc(-n2c3ccccc3c3cc(-c4ccccc4-c4ccccc4)ccc32)c(-n2c3ccccc3c3cc(-c4ccccc4-c4ccccc4)ccc32)cc1-c1cc(-c2ccccc2)nc(-c2ccccc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 4/20 0.38
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
ADORA1 P30542 5/20 0.36
ADORA2A P29274 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPK1 P28482 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
NPSR1 Q6W5P4 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
MEN1 O00255 1/20 0.35
PIM1 P11309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19919751 0.95 GABRG2 (0.44) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19913328 0.94 SQOR (0.38) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19919826 0.94 SQOR (0.38) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19909358 0.93 MYC (0.37) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19909542 0.92 AR (0.38) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19919753 0.91 GABRG2 (0.46) GABRG2GABRB3GABRA5GABRA3ADORA1
SCHEMBL19909105 0.90 MEN1 (0.36) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19909361 0.90 MYC (0.39) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19909321 0.90 MYC (0.38) SQORGABRG2GABRB3GABRA5GABRA3
SCHEMBL19919818 0.89 MYC (0.44) SQORGABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 SQOR 1580/4885GABRG2 1265/4885GABRB3 497/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 SQOR 1580/4885GABRG2 1265/4885GABRB3 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.